1-(6-Amino-9-methyl-9H-purin-2-ylethynyl)-cyclohexanol

ID: ALA52432

PubChem CID: 10754589

Max Phase: Preclinical

Molecular Formula: C14H17N5O

Molecular Weight: 271.32

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cn1cnc2c(N)nc(C#CC3(O)CCCCC3)nc21

Standard InChI:  InChI=1S/C14H17N5O/c1-19-9-16-11-12(15)17-10(18-13(11)19)5-8-14(20)6-3-2-4-7-14/h9,20H,2-4,6-7H2,1H3,(H2,15,17,18)

Standard InChI Key:  KWXSUKIAQGKUHD-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 20 22  0  0  0  0  0  0  0  0999 V2000
    8.1542   -5.5292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1542   -6.3542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9292   -5.2750    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.9292   -6.6042    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.4500   -6.7667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.4500   -5.1167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7292   -5.5375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.4042   -5.9417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7292   -6.3417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9917   -6.7542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2742   -7.1555    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5480   -7.5617    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4542   -4.2917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.2042   -7.3917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5463   -6.7284    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8493   -7.1388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5331   -8.3866    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8070   -8.7887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1231   -7.5325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1040   -8.3574    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  2  1  0
  5  2  2  0
  6  1  2  0
  7  6  1  0
  8  3  2  0
  9  7  2  0
 10  9  1  0
 11 10  3  0
 12 11  1  0
 13  6  1  0
 14  4  1  0
 15 12  1  0
 16 12  1  0
 17 12  1  0
 18 17  1  0
 19 16  1  0
 20 18  1  0
  8  4  1  0
  9  5  1  0
 20 19  1  0
M  END

Associated Targets(non-human)

Adora2b Adenosine A2b receptor (205 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 271.32Molecular Weight (Monoisotopic): 271.1433AlogP: 0.99#Rotatable Bonds:
Polar Surface Area: 89.85Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 12.97CX Basic pKa: 3.77CX LogP: 1.60CX LogD: 1.60
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.70Np Likeness Score: 0.03

References

1. Harada H, Asano O, Hoshino Y, Yoshikawa S, Matsukura M, Kabasawa Y, Niijima J, Kotake Y, Watanabe N, Kawata T, Inoue T, Horizoe T, Yasuda N, Minami H, Nagata K, Murakami M, Nagaoka J, Kobayashi S, Tanaka I, Abe S..  (2001)  2-Alkynyl-8-aryl-9-methyladenines as novel adenosine receptor antagonists: their synthesis and structure-activity relationships toward hepatic glucose production induced via agonism of the A(2B) receptor.,  44  (2): [PMID:11170626] [10.1021/jm990499b]

Source